Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia

Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia.

Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration (FDA) for the treatment of psychotic disorders. Agranulocytosis is a well-established side effect of clozapine; clozapine has also been associated with other blood dyscrasias like leukocytosis, albeit rarely. In this paper, we aim to report a case of possible clozapine-associated leukocytosis in ...

Low Dose Celecoxib Combined with Clozapine for Treatment of Schizophrenia: A Double Blind Randomized Clinical Trial

Introduction: Higher levels of pro-inflammatory cytokines in schizophrenia have suggested that dysfunctions of the immune system may play a role in this disabling condition. The current study was performed to discover if low dose celecoxib combined with clozapine may improve symptoms of schizophrenia or not. Methods:<span...

Clozapine in Treatment of Schizophrenia

The introduction of clozapine for the treatment of non responsive patients with schizophrenia has determined a real hope among patients, families and psychiatrists. This treatment is available that appears to be more effective than the standard or typical neuroleptics for many such treatment-resistant schizophrenic patients. A growing number of reports suggest that clozapine may also have a rol...

Use of Clozapine in a Patient with Schizophrenia and Polydipsia

clozapine: a new revolt in treatment of schizophrenia

clozapine is the first antipsycotic drug with a great efficacy. thirty to fifty percent of treatment-resistant schizophrenics markedly improved with clozapine. approximately, 25% of long-term patients, treated with clozapine, could be discharged. this improvement included negative as well as positive symptom areas. clozapine produced no extrapyramidal side effects. tardive dyskinesia, a major s...